Literature DB >> 22158495

Multi-field-of-view SPECT is superior to whole-body scanning for assessing metastatic bone disease in patients with prostate cancer.

Luca Giovanella1, Massimo Castellani, Sergio Suriano, Teresa Ruberto, Luca Ceriani, Luca Tagliabue, Giovanni Lucignani.   

Abstract

AIM: The aim of this study was to compare the diagnostic performance of whole-body bone scintigraphy (WBS) and multi-field-of-view single photon emission tomography (multi-FOV SPECT) with 99mTc-oxidronate (99mTc-HDP) in patients with prostate cancer (PCa).
METHODS: In a prospective study, WBS and SPECT acquisitions were performed in 194 patients with histologically confirmed PCa and serum prostate-specific antigen (PSA) levels above 10 ng/mL. Scans obtained using the two modalities were interpreted separately. Clinical and biochemical follow-up, radiological studies and biopsies served as benchmarks for the assessments. The impact of PSA level on WBS and SPECT results was also evaluated.
RESULTS: The patient-based sensitivity, specificity, accuracy, PPV and NPV values of SPECT examinations were higher than those of WBS, especially in patients with serum PSA levels <40 ng/mL.
CONCLUSION: Multi-FOV SPECT proved to be more sensitive and specific than WBS in detecting bone metastases in PCa patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158495     DOI: 10.1177/030089161109700515

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

Review 1.  Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.

Authors:  Guohua Shen; Houfu Deng; Shuang Hu; Zhiyun Jia
Journal:  Skeletal Radiol       Date:  2014-05-20       Impact factor: 2.199

2.  Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.

Authors:  Jing Zhou; Zhengxing Gou; Renhui Wu; Yuan Yuan; Guiquan Yu; Yigang Zhao
Journal:  Skeletal Radiol       Date:  2019-05-24       Impact factor: 2.199

3.  PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?

Authors:  Steven P Rowe; Margarita Mana-Ay; Mehrbod S Javadi; Zsolt Szabo; Jeffrey P Leal; Martin G Pomper; Kenneth J Pienta; Ashley E Ross; Michael A Gorin
Journal:  Clin Genitourin Cancer       Date:  2015-09-30       Impact factor: 2.872

4.  Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.

Authors:  Catherine Guezennec; Nathalie Keromnes; Philippe Robin; Ronan Abgral; David Bourhis; Solène Querellou; Romain de Laroche; Alexandra Le Duc-Pennec; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Cancer Imaging       Date:  2017-06-07       Impact factor: 3.909

Review 5.  Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis.

Authors:  Jenna Kitz; Lori E Lowes; David Goodale; Alison L Allan
Journal:  Diagnostics (Basel)       Date:  2018-04-28

6.  Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer.

Authors:  Vincent Fleury; Ludovic Ferrer; Mathilde Colombié; Daniéla Rusu; Maëlle Le Thiec; Françoise Kraeber-Bodéré; Loïc Campion; Caroline Rousseau
Journal:  Oncotarget       Date:  2018-08-03

Review 7.  Imaging diagnosis of metastatic breast cancer.

Authors:  Filippo Pesapane; Kate Downey; Anna Rotili; Enrico Cassano; Dow-Mu Koh
Journal:  Insights Imaging       Date:  2020-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.